Atrás
49
Rango del Día
$5.77
$6.18
Rango de 52 Semanas
$5.77
$15.85
Volumen
5,919,955
Promedio 50D / 200D
$7.72
/
$8.64
Cierre Anterior
$6.03
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (626 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | 8.5 | 0.4 |
| P/B | 2.1 | 2.9 |
| ROE % | 30.6 | 3.7 |
| Net Margin % | 3.0 | 3.8 |
| Rev Growth 5Y % | -0.4 | 10.0 |
| D/E | 11.7 | 0.2 |
Puntos Clave
Revenue declined -0.35% annually over 5 years
Earnings declined -78.36% over the past year
ROE of 30.56% indicates high profitability
Debt/Equity of 11.70 — high leverage
Generating 538.00M in free cash flow
P/E of 8.48 — trading at a low valuation
Crecimiento
Revenue Growth (5Y)
-0.35%
Revenue (1Y)-2.92%
Earnings (1Y)-78.36%
FCF Growth (3Y)0.00%
Calidad
Return on Equity
30.56%
ROIC10.09%
Net Margin3.01%
Op. Margin20.67%
Seguridad
Debt / Equity
11.70
Current Ratio1.82
Interest Coverage2.55
Valoración
P/E Ratio
8.48
P/B Ratio2.11
EV/EBITDA7.64
Dividend Yield0.05%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -2.92% | Revenue Growth (3Y) | -0.38% |
| Earnings Growth (1Y) | -78.36% | Earnings Growth (3Y) | -57.25% |
| Revenue Growth (5Y) | -0.35% | Earnings Growth (5Y) | -39.00% |
| Profitability | |||
| Revenue (TTM) | 6.22B | Net Income (TTM) | 187.00M |
| ROE | 30.56% | ROA | 1.45% |
| Gross Margin | 54.09% | Operating Margin | 20.67% |
| Net Margin | 3.01% | Free Cash Flow (TTM) | 538.00M |
| ROIC | 10.09% | FCF Growth (3Y) | 0.00% |
| Safety | |||
| Debt / Equity | 11.70 | Current Ratio | 1.82 |
| Interest Coverage | 2.55 | Dividend Yield | 0.05% |
| Valuation | |||
| P/E Ratio | 8.48 | P/B Ratio | 2.11 |
| P/S Ratio | 0.26 | PEG Ratio | -0.13 |
| EV/EBITDA | 7.64 | Dividend Yield | 0.05% |
| Market Cap | 1.59B | Enterprise Value | 9.81B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 6.22B | 6.40B | 6.26B | 6.17B | 6.30B |
| Net Income | 187.00M | 864.00M | 1.02B | 917.00M | 1.35B |
| EPS (Diluted) | 0.72 | 3.33 | 3.99 | 3.59 | 5.33 |
| Gross Profit | 3.36B | 3.72B | 3.75B | 3.88B | 3.92B |
| Operating Income | 1.29B | 1.49B | 1.33B | 1.71B | 1.92B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 12.87B | 13.10B | 12.06B | 10.96B | 10.68B |
| Total Liabilities | 12.12B | 12.63B | 12.13B | 11.85B | 12.19B |
| Shareholders' Equity | 752.00M | 472.00M | -70.00M | -892.00M | -1.51B |
| Total Debt | 8.80B | 9.04B | 8.93B | 9.11B | 9.36B |
| Cash & Equivalents | 574.00M | 675.00M | 693.00M | 706.00M | 737.00M |
| Current Assets | 4.35B | 4.35B | 4.51B | 3.93B | 3.76B |
| Current Liabilities | 2.39B | 2.72B | 2.92B | 2.51B | 2.60B |
Puntuaciones de Estrategias
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#165 of 658
Actividad Reciente
Entró
Contrarian Investing (David Dreman)
Mar 24, 2026